| 产品编号 | bs-43222P |
| 英文名称 | Recombinant human TSLP protein, C-His (HEK293) |
| 中文名称 | 重组人胸腺基质淋巴细胞生成素-1蛋白 |
| 别 名 | TSLP_HUMAN; Thymic stromal lymphopoietin; thymic stromal lymphopoietin; |
| 克 隆 号 | |
| 理论分子量 | 16.6 kDa |
| 检测分子量 | |
| 性 状 | Liquid |
| 浓 度 | >0.5mg/ml |
| 纯 度 | ≥ 90% as determined by SDS-PAGE. |
| 缓 冲 液 | PBS (pH=7.4) |
| 保存条件 | Stored at -70℃ or -20℃. Avoid repeated freeze/thaw cycles |
| 注意事项 | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 产品介绍 |
Thymic stromal lymphopoietin (TSLP) is a novel cytokine that was found to promote the development of murine B cells in vitro. This protein, which is expressed in a number of tissues including heart, liver and prostate, prevented apoptosis and stimulated growth of the human acute myeloid leukemia (AML)-derived cell line MUTZ-3. Anti-interleukin (IL)-7 receptor antibodies (Abs) neutralized this effect indicating that TSLP binds to at least part of the IL-7 receptor complex. TSLP induced phosphorylation of signal transducer and activator of transcription (STAT)-5. SWISS: Q969D9 Gene ID: 85480 胸腺基质淋巴细胞生成素-1(胸腺基质细胞分泌的淋巴细胞生成素-1) 为一种新型促进生长的细胞因子——胸腺基质淋巴蛋白(TSLP)可以引发炎症反应, 这种炎症反应可以引起很多过敏性疾病和哮喘。 TSLP可能是过敏性疾病最重要的引发剂,已得到科学家的重视,如果证实了 TSLP是一种起始因子,抑制TSLP可以有效地治疗哮喘和其它过敏性疾病。 |
| 产品图片 | |
| 1、抗体溶解方法 | |
| 2、抗体修复方式 | |
| 3、常用试剂的配制 | |
| 4、免疫组化操作步骤 | |
| 5、免疫组化问题解答 | |
| 6、Western Blotting 操作步骤 | |
| 7、Western Blotting 问题解答 | |
| 8、关于肽链的设计 | |
| 9、多肽的溶解与保存 | |
| 10、酶标抗体效价测定程序 | |